The Valley Desk

NCT03740724 · Interventional trial

A Study of FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea)

Overall registry status Terminated

Phase 1 · Phase 2

Conditions Morphea, Scleroderma, Scleroderma, Localized

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov